REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 81 filers reported holding REPARE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,091,043 | +14.2% | 2,242,636 | 0.0% | 14.51% | +24.7% |
Q2 2023 | $23,727,089 | +7.5% | 2,242,636 | 0.0% | 11.64% | +26.5% |
Q1 2023 | $22,067,538 | -33.1% | 2,242,636 | 0.0% | 9.20% | -33.4% |
Q4 2022 | $32,989,176 | +21.3% | 2,242,636 | 0.0% | 13.80% | +33.2% |
Q3 2022 | $27,203,000 | -13.3% | 2,242,636 | 0.0% | 10.36% | -21.7% |
Q2 2022 | $31,374,000 | -1.8% | 2,242,636 | 0.0% | 13.24% | +21.3% |
Q1 2022 | $31,935,000 | -32.5% | 2,242,636 | 0.0% | 10.92% | +6.8% |
Q4 2021 | $47,297,000 | -19.6% | 2,242,636 | 0.0% | 10.22% | -25.1% |
Q3 2021 | $58,847,000 | -16.9% | 2,242,636 | -1.3% | 13.64% | +3.6% |
Q2 2021 | $70,815,000 | -11.4% | 2,271,177 | -12.8% | 13.16% | -14.7% |
Q1 2021 | $79,889,000 | -22.5% | 2,603,089 | -13.3% | 15.43% | +5.9% |
Q4 2020 | $103,029,000 | +11.5% | 3,003,772 | 0.0% | 14.58% | -15.4% |
Q3 2020 | $92,426,000 | -0.8% | 3,003,772 | 0.0% | 17.24% | -37.8% |
Q2 2020 | $93,177,000 | – | 3,003,772 | – | 27.72% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |